The global mastopexy market size accounted for US$ 1,347 Mn in 2021 and is estimated to reach US$ 2,175 Mn by 2030, with a significant CAGR of 5.8% from 2022 to 2030.
Mastopexy, also known as breast lift, is a cosmetic breast surgery procedure that lifts the breasts. Its general idea is to lift and shape sagging or ptotic breast while minimizing visible scars. The procedure also eliminates excess skin around the breasts and shrinks the areola — the pigmented circle around the nipple. Breast sagging can occur with aging, hormonal changes, breastfeeding, and weight loss. Mastopexy is generally less painful than other cosmetic breast operations and requires little follow-up care. This treatment is performed with extreme caution since plastic surgeons must assure the tissue viability of the nipple-areola complex (NAC) in order to ensure the functional sensitivity of the breasts for breastfeeding and lactation.Market Growth Drivers
|Market Size 2021||US$ 1,347 Mn|
|Market Forecast 2028||US$ 2,175 Mn|
|CAGR||5.8% During 2022 - 2030|
|Analysis Period||2018 - 2030|
|Forecast Data||2022 - 2030|
|Segments Covered||By Technique, By End-Use, And By Geography
|Regional Scope||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa|
|Key Companies Profiled||ALLERGAN, Cynosure, Inc., Galderma, GC Aesthetics, Mentor Worldwide LLC, POLYTECH Health & Aesthetics, LIPOELASTIC, Lumenis, Sientra, Inc., SOLTA Medical, and Syneron Medical.|
||Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis|
10 hrs of free customization and expert consultation
The growing number of breast lifting procedures across the world is the primary factor boosting the growth of the global mastopexy market. The American Society of Plastic Surgeons (ASPS) data shows sustained growth in cosmetic surgeries over the last few years. In 2017, 17.5 million surgical and minimally invasive cosmetic operations were performed in the United States, according to yearly plastic surgery procedural statistics. Among them, more than 100,000 mastopexies were performed in the United States.
The growing prominence of physical appearance is another leading factor that is expanding the mastopexy market share. Psychologically, a mastopexy treatment to address breast ptosis is not recommended by a medical cause or a physical reason, but by the woman's self-image; that is, the woman's combination of aesthetic, physical, and mental health requirements. Thus, the trend of aesthetic procedures has been on a boom, especially the population of developed nations.
Mastopexy is typically required for older females as their breasts sag with age. Breasts of breastfeeding mothers and pregnant women sag as a result of their situations. However, due to post-surgery problems, these operations are not performed on these women. Post-surgery complications of mastopexy are expected to hinder the market growth for a noteworthy period of time. Some of the most common complications that have been observed in women are scarring on breasts, changes in nipple or breast sensation, and difficulty in breastfeeding. Furthermore, developing healthcare infrastructure along with increased technological advancements in the aesthetic industry is predicted to reverse the trend, resulting in various growth prospects for the market in the approaching years.
The global mastopexy market is segmented based on technique, end-use, and geography.
Market By Technique
Market By End-Use
Mastopexy Market Regional Overview
Middle East & Africa (MEA)
The rising number of breast enhancement surgeries boosts the North America Mastopexy market revenue
The regional segmentation is given as North America, Latin America, Asia-Pacific, Europe, and the Middle East & Africa (MEA). According to a regional study, the North America region earned the majority of market revenue in 2021 and is expected to continue in the next years. Some of the factors driving regional growth include the rising geriatric population and increased healthcare expenditure. According to the American Society of Plastic Surgeons figures, Americans are resorting to new and imaginative ways to shape their bodies, with minimally invasive cosmetic operations increasing nearly 200 percent since 2000. The second-largest mastopexy market is occupied by Europe. This is majorly due to the increasing demand for aesthetics, increased per capita income, and the presence of advanced healthcare facilities in countries such as Germany, the UK, and France.
Meanwhile, the Asia-Pacific region is expected to develop at the quickest CAGR over the next few years. The market for the Asia-Pacific region is growing due to the changing lifestyle among the population, increasing awareness about women's health, and surging investments in the healthcare sector. Moreover, this region has also witnessed a growing number of cosmetic procedures in countries such as Thailand, Australia, and Malaysia among others. Thus, the Asia-Pacific mastopexy market revenue is expanding at the fastest rate.
Some of the top vendors offered in the professional report include ALLERGAN, Cynosure, Inc., Galderma, GC Aesthetics, Mentor Worldwide LLC, POLYTECH Health & Aesthetics, LIPOELASTIC, Lumenis, Sientra, Inc., SOLTA Medical, and Syneron Medical.
The estimated value of global Mastopexy market in 2021 was accounted to be US$ 1,347 Mn.
The projected CAGR of Mastopexy market during the analysis period of 2022 to 2030 is 5.8%.
The prominent players of the global Mastopexy market involve ALLERGAN, Cynosure, Inc., Galderma, GC Aesthetics, Mentor Worldwide LLC, POLYTECH Health & Aesthetics, LIPOELASTIC, Lumenis, Sientra, Inc., SOLTA Medical, and Syneron Medical.
North America held the dominating share for Mastopexy during the analysis period of 2022 to 2030.
Asia-Pacific region exhibited fastest growing CAGR for Mastopexy during the analysis period of 2022 to 2030.
Growing prominence on physical appearance, rising female geriatric population, rising trend of aesthetic procedures all contribute to the expansion of the worldwide mastopexy market.
Based on Technique, full-mastopexy segment held the maximum share for Mastopexy market in 2021.